Budigalimab
Modify Date: 2024-04-06 10:52:58
Budigalimab structure
|
Common Name | Budigalimab | ||
|---|---|---|---|---|
| CAS Number | 2098225-93-3 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of BudigalimabBudigalimab (ABBV 181; PR 1648817) is a humanized IgG1 monoclonal antibody targeting programmed cell death 1 (PD-1) receptor. Budigalimab is Fc mutated thus to reduce Fc receptor interactions and limit effector function[1]. |
| Name | Budigalimab |
|---|
| Description | Budigalimab (ABBV 181; PR 1648817) is a humanized IgG1 monoclonal antibody targeting programmed cell death 1 (PD-1) receptor. Budigalimab is Fc mutated thus to reduce Fc receptor interactions and limit effector function[1]. |
|---|---|
| Related Catalog | |
| Target |
programmed cell death 1 (PD-1) receptor[1] |
| References |
| No Any Chemical & Physical Properties |